ETL GLOBAL is proud to announce that In Extenso Innovation Croissance, the innovation arm of its French Partner In Extenso, has been distinguished in several categories at the 2025 Décideurs (Leaders League) rankings.
This year’s classification places In Extenso Innovation Croissance in the “Highly Recommended” tier for the third consecutive year in the Health, Pharma & Biotechnology – Development & Marketing of Health Products (pharma, medical devices) category. This recognition reflects its established role within France’s health innovation advisory field and highlights its work with hospitals, research institutions, start-ups and established companies operating across health-related fields.
This result stands alongside three “Excellent” classifications achieved by the firm in the following categories:
- Energy & Environment – Corporate Social Responsibility
- Partners of the Finance Department – Innovation Financing (R&D, CIR)
- Innovation, Technologies & Telecoms – Innovation Strategy & Management.
These distinctions highlight the role of In Extenso Innovation Croissance as a specialised advisory firm supporting organisations in shaping and financing their innovation strategies. Active across sectors such as life sciences, energy and agri-food, the firm bridges research, industry and operational stakeholders, enabling clients to advance projects that combine technological development with measurable impact.
ETL GLOBAL congratulates the team at In Extenso Innovation Croissance, together with the wider In Extenso group, for these achievements and the continued quality of their advisory work.
Learn more by reading the press release published by In Extenso Innovation Croissance (in French language.)
Follow In Extenso Innovation Croissance and In Extenso on LinkedIn to stay updated on their latest developments.
